Cleveland Clinic completed its first prescription drone deliveries to patients’ homes last week, and on Monday the health system announced the service as a long-term program, not a pilot. Zipline flies the missions from the Clinic’s Beachwood Administrative Campus outside Cleveland, serving patients within 8 kilometers (5 miles) at no extra cost. The service is optional, and for now only patients already enrolled in the Clinic’s home delivery program for certain medications qualify.
Just over three weeks ago, when DroneXL walked through this program’s construction phase, the launch pads in Beachwood were still being assembled. The packages are now moving.
The launch also comes with a number that matters more than the ribbon cutting. Zipline tells DroneXL that deliveries in the United States now make up more than 70 percent of its daily volume worldwide. The company that built its name flying blood across Rwanda has quietly become an American delivery operation first.
A Tethered Pod From 91 Meters, Tracked In MyChart
A Cleveland Clinic pharmacy technician loads each prescription into a secure drop box, a Zipline aircraft retrieves it autonomously, flies to the patient’s address, holds at up to 91 meters (300 feet), and lowers the package to the ground on a tethered pod without ever landing.
The aircraft is Zipline’s Platform 2, the system DroneXL watched complete its first customer delivery in January 2025. At the drop box, the technician enters an individualized code before the handoff, a security step Spectrum News 1 reported from Beachwood. Patients learn their medications qualify through their electronic patient portal, and each flight can be followed through a tracking link in MyChart, according to the Clinic’s announcement.
Two limits define the first phase. The service reaches only the Beachwood radius, and controlled substances stay off the aircraft for now, the one line in the announcement that defines the program’s current ceiling.
Long-Term Is The Word Doing The Work
Cleveland Clinic and Zipline are calling this the first long-term deployment of a prescription drug drone delivery program by a U.S. health system, and every word in that phrase is load-bearing: a standing service inside the health system’s own pharmacy operation, with an expansion roadmap instead of an end date.
The arc from announcement to launch shows what that commitment cost. Cleveland Clinic and Zipline announced this program in October 2023, which puts nearly three years between the press release and the first package on a lawn. When DroneXL covered the construction phase in July, we also unpacked the first-in-the-nation family tree, because drones have carried American prescriptions before. What no U.S. health system had done until last week is fold drone delivery into its own pharmacy workflow: the pharmacist who fills the bottle also loads the drop box, and the delivery alert arrives through the same patient portal as everything else in a patient’s care. Chief Pharmacy Officer Lindsey Amerine called the program another way of “extending the reach of our services beyond the walls of our facilities.”
The published roadmap points at more: additional locations, other medications, lab samples, medically tailored meals, and supplies. And the next entrant is already on the calendar. Zipline and BayCare announced a Tampa-area medical network in early July with first flights planned for late 2027, which hands Cleveland Clinic more than a year of real-world data before Florida’s program leaves the ground. Whatever hospital pharmacy directors decide about drones in 2028, they will decide it by looking at Beachwood.
Zipline’s Center Of Gravity Has Crossed The Atlantic
Zipline tells DroneXL that United States deliveries now account for more than 70 percent of its daily volume worldwide, a reversal for a company that spent its first decade proving medical drone logistics over Rwanda and Ghana before American suburbs became the main stage.
The rest of the figures the company shared with DroneXL this week sketch the scale. Zipline says it now delivers to more than 5,000 hospitals and health facilities globally and has moved tens of millions of medical products since its first flights in 2016. Its consumer side runs alongside the medical work: Texas customers can order from more than 100,000 items across brands like Walmart and Chipotle through the Zipline app, with an average click-to-delivery time of 18 minutes. Ohio now joins Arkansas and Texas on the company’s U.S. commercial map. Zipline’s President of U.S. Healthcare Hillary Brendzel put the patient pitch plainly: “That’s one less errand to run.”
The 70 percent figure lands differently if you have followed where Zipline came from. Last August, DroneXL reported that the company’s vaccine deliveries in Nigeria’s Kaduna State sat suspended after a change in state government, despite more than 225,000 medical items flown to rural clinics in under a year. The lesson from Kaduna was that aerial health logistics built on political goodwill dies with the administration that signed it. Beachwood is the structural opposite: the institution that owns the pharmacy and the patient relationship also owns the delivery program.
DroneXL’s Take
I have covered Zipline long enough to remember when the entire story was Rwanda. In January 2025 we covered Platform 2’s first customer delivery, and the question then was whether the machine that mastered blood bags could earn a living in American neighborhoods. A hospital system just answered by putting it on the payroll. The wire coverage this week fixates on the word first. The word that will matter in five years is long-term. This industry has produced no shortage of drone delivery firsts. What it has struggled to produce is drone delivery that is still flying two budget cycles later.
Forget the tether. The convincing part is the plumbing. The delivery link lands in the same MyChart thread as the lab results, and the pharmacist filling the bottle loads the drop box. When Kaduna’s flights stopped, the program was a vendor contract a new governor could shelve, and nobody in the statehouse owned it. Nobody at Cleveland Clinic can shelve this without unplugging a piece of their own pharmacy. That is what long-term actually means.
The economics run through programs exactly like this one. When DroneXL dug into Zipline’s $7.6 billion valuation in January, the conclusion was that healthcare partnerships, not burritos, would end up driving the margins. Beachwood is that conclusion with a launch pad. The regulatory calendar is finally moving toward it too: the FAA released its Part 108 proposal for routine beyond visual line of sight flight one year ago today, and the draft final rule has been under review at the Office of Information and Regulatory Affairs since July 10, the last stop before publication. That review runs up to 90 days, which points to a published final rule late this year or early next. Every delivery network in this country still flies on exemptions and case-by-case approvals; the day Part 108 publishes, Beachwood stops being a bespoke achievement and starts being a template.
None of this is abstract for the person on the other end. The patient who opts in trades a pharmacy line for a pod on the lawn and a tracking link on their phone. Drones win the public over one boring, useful delivery at a time, and a prescription arriving softly in a Cleveland backyard is the best advertisement this industry gets. More of this, please.
Sources: Cleveland Clinic Newsroom, Spectrum News 1, Airdata, and figures provided to DroneXL by Zipline.
DroneXL uses automated tools to support research and source retrieval. All reporting and editorial perspectives are by Haye Kesteloo.
